Key facts
- Ridgeback Capital is a venture capital firm based in New York, New York with 6 tracked portfolio companies.
- Notable positions include Freenome, Crisp, Arbor Biotechnologies, Stratus Therapeutics, Aro Biotherapeutics.
- The team roster lists 4 people.
About Ridgeback Capital
Founded in 2006, Ridgeback Capital is a venture capital firm based in New York. The firm prefers to invest in companies operating in the life science sector.
Free account
See the whole book
- ·Watchlist + alerts for Ridgeback Capital's activity
Create free account
No card required
Portfolio, priced
6 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | $2.2B | — | |
| Crisp | — | $630.0M | — | |
| Arbor Biotechnologies | — | $238.9M | — | |
| Stratus Therapeutics | — | $210.0M | — | |
| Aro Biotherapeutics | — | $181.5M | — | |
| Hinge Bio | Drug Discovery | $46.0M | — |
Team
4 people on record — 4 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Ridgeback Capital invest in?
- Ridgeback Capital has 6 recorded portfolio companies, including Freenome, Crisp, Arbor Biotechnologies, Stratus Therapeutics.